Epizyme is a startup based in Australia, most recent round Pre-ipo.
Epizyme is a company headquartered in Australia. Its most recent tracked round is Pre-ipo.
Epizyme is a biopharmaceutical company focused on the discovery and development of novel epigenetic therapies for cancer.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.